D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$708M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$614M |
| 3 |
Merck
MRK
|
+$521M |
| 4 |
Bank of America
BAC
|
+$492M |
| 5 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$646M |
| 2 |
Tesla
TSLA
|
+$607M |
| 3 |
Microsoft
MSFT
|
+$491M |
| 4 |
Accenture
ACN
|
+$482M |
| 5 |
Broadcom
AVGO
|
+$438M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.84% |
| 2 | Consumer Discretionary | 9.28% |
| 3 | Healthcare | 6.84% |
| 4 | Financials | 6.63% |
| 5 | Industrials | 5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Open Text
OTEX
$6.02B
| $2.86M | ﹤0.01% |
85,826
-489,668
| -85% | -$15.4M |
|
2277
Pan American Silver
PAAS
$18.2B
| $2.86M | ﹤0.01% |
136,802
+113,202
| +480% | +$2.39M |
|
2278
Upland Software
UPLD
$14.4M
| $2.85M | ﹤0.01% |
114,639
-11,792
| -9% | -$272K |
|
2279
ODDITY Tech
ODD
$784M
| $2.84M | ﹤0.01% |
70,220
-128,703
| -65% | -$4.96M |
|
2280
HealthStream
HSTM
$843M
| $2.83M | ﹤0.01% |
98,292
-15,610
| -14% | -$447K |
|
2281
PUT
Axsome Therapeutics
AXSM
$12.1B
| $2.83M | ﹤0.01% |
31,500
| – | – |
|
2282
Main Street Capital
MAIN
$5.14B
| $2.82M | ﹤0.01% |
+56,342
| New | +$2.82M |
|
2283
Curtiss-Wright
CW
$26.9B
| $2.82M | ﹤0.01% |
8,585
-5,848
| -41% | -$1.73M |
|
2284
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.39B
| $2.82M | ﹤0.01% |
131,200
+46,400
| +55% | +$965K |
|
|
JWN
2285
CALL
DELISTED
Nordstrom
JWN
| $2.82M | ﹤0.01% |
125,400
+24,600
| +24% | +$546K |
|
2286
Applied Industrial Technologies
AIT
$12.9B
| $2.82M | ﹤0.01% |
12,617
-2,160
| -15% | -$440K |
|
2287
Ormat Technologies
ORA
$6.05B
| $2.81M | ﹤0.01% |
36,549
-73,943
| -67% | -$5.48M |
|
2288
PUT
Danaher
DHR
$140B
| $2.81M | ﹤0.01% |
+10,100
| New | +$2.67M |
|
2289
Xeris Biopharma Holdings
XERS
$1.42B
| $2.81M | ﹤0.01% |
985,015
+466,991
| +90% | +$1.2M |
|
2290
Dentsply Sirona
XRAY
$2.7B
| $2.81M | ﹤0.01% |
103,691
-410,131
| -80% | -$10.5M |
|
2291
CALL
Northern Oil and Gas
NOG
$2.16B
| $2.8M | ﹤0.01% |
79,200
-17,800
| -18% | -$679K |
|
|
PLL
2292
CALL
DELISTED
Piedmont Lithium
PLL
| $2.8M | ﹤0.01% |
313,600
-132,500
| -30% | -$1.2M |
|
2293
PUT
Intuit
INTU
$85.6B
| $2.79M | ﹤0.01% |
4,500
+3,500
| +350% | +$2.23M |
|
2294
Mercury Systems
MRCY
$5.97B
| $2.79M | ﹤0.01% |
75,440
-130,509
| -63% | -$4.59M |
|
2295
LiveRamp
RAMP
$2.29B
| $2.79M | ﹤0.01% |
112,583
+10,740
| +11% | +$293K |
|
|
VMEO
2296
DELISTED
Vimeo
VMEO
| $2.79M | ﹤0.01% |
551,716
-25,557
| -4% | -$116K |
|
|
AMTM
2297
Amentum Holdings
AMTM
$5.73B
| $2.79M | ﹤0.01% |
+86,390
| New | +$2.46M |
|
2298
CALL
CRISPR Therapeutics
CRSP
$4.68B
| $2.79M | ﹤0.01% |
59,300
-7,300
| -11% | -$370K |
|
2299
Telos
TLS
$344M
| $2.78M | ﹤0.01% |
774,895
-210,704
| -21% | -$754K |
|
2300
PUT
Lumentum
LITE
$50.7B
| $2.78M | ﹤0.01% |
43,800
| – | – |
|
Similar funds
D.E. Shaw & Co's Q3 2024 Portfolio in Review
As of Q3 2024, D.E. Shaw & Co held 5,052 positions worth $116B, up 8.9% from $107B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
D.E. Shaw & Co's Q3 2024 filing shows 599 new, 1,568 increased, 1,742 reduced and 558 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 1,429,800 shares worth $115M. The largest sale was Adobe, an estimated $646M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q3 2024 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 1,429,800 shares worth $115M.
- D.E. Shaw & Co added most to NVIDIA in Q3 2024, an estimated $708M increase.
- D.E. Shaw & Co's biggest Q3 2024 reduction was Adobe, cutting an estimated $646M.
- D.E. Shaw & Co fully exited WestRock Company in Q3 2024, selling an estimated $148M.
- D.E. Shaw & Co's ten largest holdings make up 9.6% of its $116B portfolio in Q3 2024.
- D.E. Shaw & Co opened 599 new positions and closed 558 in Q3 2024.
- D.E. Shaw & Co's portfolio value rose 8.9% quarter-over-quarter to $116B.
Based on D.E. Shaw & Co's 13F filing for Q3 2024, filed 14 Nov 2024.